Management of Capillary Malformations
Clinics in Plastic Surgery · 2026
DOI: 10.1016/j.cps.2026.05.007 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinics in Plastic Surgery, 2026. Verfasst von Pierre-Olivier Grenier und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Pierre-Olivier.Grenier@childrens.…. Hauptthemen laut MEDLINE: Port-Wine Stain, Capillaries. Die Arbeit nennt 69 Literaturangaben.
Abstract (Originalsprache)
Capillary malformation (CM), or port wine birthmark, is a congenital low-flow vascular malformation of dilated capillaries and postcapillary venules. It often affects the face and may darken, thicken, or develop nodules over time. Most CMs are isolated but can be associated with syndromes such as Sturge-Weber, characterized by a facial CM, leptomeningeal vascular malformation, and ocular findings such as glaucoma. CMs also occur in other syndromes, emphasizing the need for thorough clinical evaluation. Management is multidisciplinary, with pulsed-dye laser as the gold standard treatment; excision may be required for tissue overgrowth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: Pierre-Olivier.Grenier@childrens.harvard.edu.
- Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Grenier, P. O., & Liang, M. G. (2026). Management of Capillary Malformations. Clinics in Plastic Surgery. https://doi.org/10.1016/j.cps.2026.05.007
Vancouver
Grenier PO, Liang MG. Management of Capillary Malformations. Clinics in Plastic Surgery. 2026. doi:10.1016/j.cps.2026.05.007
BibTeX
@article{Grenier2026,
author = {Grenier, Pierre-Olivier and Liang, Marilyn G},
title = {Management of Capillary Malformations},
journal = {Clinics in Plastic Surgery},
year = {2026},
doi = {10.1016/j.cps.2026.05.007}
}
EUVIMED